Ventricular fibrillation and ventricular tachycardia post-SARS-CoV-2-targeted mRNA/viral vector vaccination
Heart Rhythm O2
.
2023 Nov 2;4(12):826-828.
doi: 10.1016/j.hroo.2023.11.001.
eCollection 2023 Dec.
Authors
Ashish Kumar
1
,
Mariam Shariff
2
,
Justin Lee
3
,
Siddarth Agarwal
4
,
Zain Asad
5
,
Daniel C DeSimone
4
6
,
Abhishek Deshmukh
6
,
Christopher V DeSimone
6
Affiliations
1
Department of Internal Medicine, Cleveland Clinic Akron General, Akron, Ohio.
2
Department of General Surgery, Mayo Clinic, Rochester, Minnesota.
3
Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio.
4
Department of Infectious Disease, Mayo Clinic, Rochester, Minnesota.
5
Department of Cardiovascular Medicine, University of Oklahoma, Oklahoma City, Oklahoma.
6
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
PMID:
38204459
PMCID:
PMC10774661
DOI:
10.1016/j.hroo.2023.11.001
No abstract available
Keywords:
Adverse effect; SARS-CoV-2; Vaccine; Ventricular fibrillation; Ventricular tachycardia.